ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Qilian International Holding Group Ltd

Qilian International Holding Group Ltd (QLI)

0.7897
0.0546
( 7.43% )
Updated: 15:47:58

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.7897
Bid
0.6743
Ask
0.77
Volume
21,646
0.6421 Day's Range 0.7898
0.3551 52 Week Range 1.2974
Market Cap
Previous Close
0.7351
Open
0.6836
Last Trade
160
@
0.7897
Last Trade Time
15:47:58
Financial Volume
$ 15,335
VWAP
0.708462
Average Volume (3m)
174,000
Shares Outstanding
35,750,000
Dividend Yield
-
PE Ratio
-3.40
Earnings Per Share (EPS)
-0.22
Revenue
46.47M
Net Profit
-7.78M

About Qilian International Holding Group Ltd

Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and ferti... Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generate most of the revenue. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Grand Cayman, Cym
Founded
1970
Qilian International Holding Group Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker QLI. The last closing price for Qilian was $0.74. Over the last year, Qilian shares have traded in a share price range of $ 0.3551 to $ 1.2974.

Qilian currently has 35,750,000 shares outstanding. The market capitalization of Qilian is $26.46 million. Qilian has a price to earnings ratio (PE ratio) of -3.40.

QLI Latest News

Qilian International Holding Group Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule

Qilian International Holding Group Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule PR Newswire JIUQUAN, China, Jan. 12, 2024 JIUQUAN, China, Jan. 12, 2024 /PRNewswire/...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.109716.13235294120.680.9640.6421349450.84298477CS
40.169727.37096774190.620.9640.55014501890.71265626CS
120.197733.39527027030.5920.9640.35511740000.6916738CS
260.209736.15517241380.580.9640.3551913540.68217799CS
52-0.3803-32.50427350431.171.29740.3551469310.6868725CS
156-3.5603-81.84597701154.354.990.3551283901.845722CS
260-7.2203-90.14107365798.01220.3551746216.41593116CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.00
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 0.00
(0.00%)
0
AADIAadi Bioscience Inc
$ 0.00
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 0.00
(0.00%)
0
AACGATA Creativity Global
$ 0.00
(0.00%)
0

QLI Discussion

View Posts
TimeFades TimeFades 2 weeks ago
Another pump n dump
πŸ‘οΈ0
stock1ace1 stock1ace1 4 weeks ago
Front loaded p&d
πŸ‘οΈ0
Awl416 Awl416 4 weeks ago
Woof
πŸ‘οΈ0
wesley_ wesley_ 3 years ago
$5.20 nice
πŸ‘οΈ0
Surfacetite Surfacetite 3 years ago
Saw this $19 premkt and figured I wait.

Got in at 12.22.

That low float got me.
πŸ‘οΈ0
realtmg realtmg 3 years ago
Looking good here
πŸ‘οΈ0
$treet $inatra $treet $inatra 3 years ago
Quite the ride on this low float! Priced @ $5 - Opened @ $8 - High of $22 all in 1 day
πŸ‘οΈ0
$treet $inatra $treet $inatra 3 years ago
$QLI ipo today https://www.streetinsider.com/Corporate+News/Qilian+International+Holding+Group+Ltd+%28QLI%29+Prices+5M+Share+IPO+at+%245Sh/17810169.html


Qilian International Holding Group Ltd (QLI) Prices 5M Share IPO at $5/Sh

Qilian International Holding Group Limited (NASDAQ: QLI), a China-based pharmaceutical and chemical products manufacturer, today announced the pricing of its initial public offering ("Offering") of 5,000,000 ordinary shares at a public offering price of US$5.00 per share. The ordinary shares have been approved for listing on the Nasdaq Global Market and are expected to commence trading on January 12, 2021 under the ticker symbol β€œQLI”.

The Company expects to receive aggregate gross proceeds of US$25 million from this Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 750,000 ordinary shares at the public offering price, less underwriting discounts. The Offering is expected to close on or about January 14, 2021, subject to the satisfaction of customary closing conditions.

Proceeds from the Offering will be used for fixed asset investment in Oxytetracycline API production facilities, construction of an organic-waste treatment facility, fixed asset investment in Heparin Sodium Preparation facilities, and marketing expenses for Gan Di Xin ®.

The Offering is being conducted on a firm commitment basis. Univest Securities, LLC is acting as the representative of the underwriters and lead book-running manager for the Offering. Loop Capital Markets and Alexander Capital L.P. are acting as co-managers for the Offering. Hunter Taubman Fischer & Li LLC acted as counsel to the Company, and Ortoli Rosenstadt LLP acted as counsel to Univest Securities, LLC in connection with the Offering.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock